| 000 | 01577 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515005247.0 | ||
| 264 | 0 | _c20071004 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a0168-8227 | ||
| 024 | 7 |
_a10.1016/j.diabres.2005.09.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeki, N | |
| 245 | 0 | 0 |
_aDifferential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy. _h[electronic resource] |
| 260 |
_bDiabetes research and clinical practice _cMay 2006 |
||
| 300 |
_a135-41 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiotensin II _xblood |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xpharmacology |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPeptidyl-Dipeptidase A _xblood |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 2 _xdrug effects |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xblood |
| 700 | 1 | _aHashimoto, N | |
| 700 | 1 | _aSuzuki, Y | |
| 700 | 1 | _aYagui, K | |
| 700 | 1 | _aSaito, Y | |
| 773 | 0 |
_tDiabetes research and clinical practice _gvol. 72 _gno. 2 _gp. 135-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.diabres.2005.09.015 _zAvailable from publisher's website |
| 999 |
_c15914312 _d15914312 |
||